Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis

NCT00963508 is registered in ClinicalTrials.gov with Sun Pharmaceutical Industries, Inc. as lead sponsor.

NCT NCT00963508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Phase III Study to Evaluate Malathion Gel 0.5% Formulation, for the Control of Head Lice in Pediatric Subjects and Adult Subjects With Pediculosis Capitis
Lead sponsor
Sun Pharmaceutical Industries, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2009
Completion date
March 31, 2010
Enrollment
403 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

pediculosis